DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Santos-Gallego CG, Requena-Ibanez JA, San Antonio R. et al
Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics.
J Am Coll Cardiol 2019;
73: 1931-1944 . doi:10.1016/j.jacc.2019.01.056
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.